KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 126 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $36,341,000 | +222.0% | 482,556 | +114.4% | 2.98% | +194.0% |
| Q1 2015 | $11,287,000 | +22.4% | 225,062 | -20.0% | 1.01% | -4.9% |
| Q3 2014 | $9,221,000 | -57.1% | 281,479 | -49.8% | 1.06% | -59.2% |
| Q2 2014 | $21,501,000 | +22.0% | 560,356 | +26.4% | 2.61% | +23.9% |
| Q1 2014 | $17,627,000 | -15.2% | 443,326 | -20.5% | 2.10% | -17.9% |
| Q4 2013 | $20,777,000 | +99.2% | 557,761 | +144.4% | 2.56% | +63.2% |
| Q3 2013 | $10,430,000 | +250.1% | 228,218 | +107.2% | 1.57% | +199.2% |
| Q2 2013 | $2,979,000 | +13.1% | 110,118 | +1.8% | 0.52% | +8.7% |
| Q1 2013 | $2,634,000 | – | 108,118 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |